Brief: Bone Therapeutics, Rigenerand Partner On Cell Therapy

Biosenic SA

14/01/2021 06:05

Jan 14 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * BONE THERAPEUTICS AND RIGENERAND SIGN PARTNERSHIP FOR CELL
THERAPY PROCESS DEVELOPMENT
    * TODAY ANNOUNCE SIGNING OF A FIRST AGREEMENT FOR A PROCESS
DEVELOPMENT PARTNERSHIP
    * RIGENERAND WILL CONTRIBUTE TO IMPROVING PROCESSES INVOLVED
IN
DEVELOPMENT AND MANUFACTURE OF BONE THERAPEUTICS' MSC BASED
ALLOGENEIC DIFFERENTIATED CELL THERAPY PRODUCTS
    * SCOPE OF COLLABORATIONS BETWEEN BONE THERAPEUTICS AND
RIGENERAND
AIMS TO FOCUS ON DIFFERENT ASPECTS OF PRODUCT AND PROCESS
DEVELOPMENT FOR BONE THERAPEUTICS' EXPANDING THERAPEUTIC
PORTFOLIO
    * FIRST COLLABORATION BETWEEN TWO ORGANIZATIONS WILL
INITIALLY
FOCUS ON AUGMENTED PROFESSIONAL BONE-FORMING CELLS
    * THERE IS ALSO POTENTIAL FOR BONE THERAPEUTICS TO BROADEN
ITS
THERAPEUTIC TARGETS

Source text for Eikon:  ID:nGNE5PRfhg 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))